BACKGROUND: Poor medication adherence contributes to negative treatment response,
symptom relapse, and hospitalizations in schizophrenia. Many health plans use claims …

Objective: This analysis assessed rates of medication adherence and pre-dictors of
nonadherence and hospitalization among patients treated with long-acting injectable and …

Nonadherence to antipsychotic medications is widespread and compromises the outcome of
patients with schizophrenia. Using the MarketScan Medicare claims database, this study …

Introduction To quantify early nonadherence to antipsychotic medications in patients with
schizophrenia and its impact on short-term antipsychotic adherence, healthcare utilization …

Background Adherence to antipsychotics for schizophrenia is associated with favorable
clinical outcomes. This study compared annual mental-health service utilization by recent …

OBJECTIVE: Pharmacy refill records were used to compare medication adherence in
outpatient veterans receiving typical versus atypical antipsychotic medications. METHOD …

Background Previous studies have used cross-sectional designs to assess factors
associated with adherence to antipsychotics giving little information about patients' …

Objective: Approximately 40% of patients with schizophrenia are poorly adherent to their
antipsychotics at any given time. However, little is known about patients' adherence over …

Background Non-adherence to psychotropic medications is common in schizophrenia and
bipolar disorders (BDs) leading to adverse outcomes. We examined patterns of …

Objectives: This study aimed to prospectively identify the best single predictor and the best
set of predictors of risk for nonadherence with antipsychotic medication in the treatment of …